- Efficacy and safety of daclatasvir and asunaprevir for hepatitis C virus genotype 1b infection
-
Nam HC, Lee HL, Yang H, Song MJ
- KMID: 2373122
- Clin Mol Hepatol.
- 2016 Jun;22(2):259-266.
- doi: 10.3350/cmh.2016.0020
BACKGROUND/AIMS: The treatment strategy for hepatitis C virus (HCV) has been changing rapidly since the introduction of direct-acting antivirals such as daclatasvir (DCV) and asunaprevir (ASV). We evaluated the efficacy... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of Combination Therapy with Celecoxib and Doxycycline on Neointimal Hyperplasia and Inflammatory Biomarkers in Coronary Artery Disease Patients Treated with Bare Metal Stents
-
Kim WH, Ko YG, Kang KW, Kim JS, Kim BK, Choi D, Hong MK, Jang Y
- KMID: 1779688
- Yonsei Med J.
- 2012 Jan;53(1):68-75.
- doi: 10.3349/ymj.2012.53.1.68
PURPOSE: Cyclooxygenase (COX)-2 and matrix metalloproteinase (MMP)-9 play a key role in the pathogenesis of in-stent restenosis. We investigated the effect of a short-term therapy of celecoxib, a COX-2 inhibitor,... -
- CITED
-
- Close
- SHARE
-
- Close
